Nevertheless, clinical pan-TNF intervention leads to concerns of the off-target effect (e.g., fever, hypotension, tuberculosis, and malignancy) as the TNF signaling pathway is a master regulator of innate immunity (Steeland et al., 2018), and TNFR1 is expressed widely in most cell types. The gene discussed is TNF; the disease is tuberculosis.